Pyxis Oncology, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-10.1M | $-11.6M | $1.5M | $44.0K |
| FY2021 | $-35.3M | $-35.9M | $540.0K | $6.4M |
| FY2022 | $-89.3M | $-95.7M | $6.4M | $15.8M |
| FY2023 | $-70.7M | $-77.4M | $6.7M | $16.9M |
| FY2024 | $-57.7M | $-57.9M | $237.0K | $12.9M |
| FY2025 | $-63.5M | $-63.5M | $9.0K | $11.8M |